Dr Dan Rogerson

CEO, GenomeKey

Dr. Daniel Rogerson is a molecular biologist with a background in developing in vitro diagnostics for sepsis detection, protein engineering, DNA sequencing and various molecular techniques. Daniel completed his PhD and postdoctoral studies at the MRC Laboratory for Molecular Biology, Cambridge University. Daniel developed a range of techniques to advance in vitro and in vivo directed evolution of biological molecules. Daniel has previously worked within biotech targeted towards sepsis diagnostic development and as lead for synthetic biology research at the Ministry of Defence.